Sterilization Modalities: Material Compatibility and Degradation

Packaging designed to maintain sterility of medical, pharmaceutical, or laboratory products until point of use.

Overview and purpose

Sterile packaging provides a protective barrier that preserves a product’s microbial sterility, physical integrity, and functional performance during storage, transport, and until first use. In medical, pharmaceutical, and some high-value industrial applications, the packaging must be compatible with the chosen sterilization modality (for example, Ethylene Oxide, Gamma Irradiation, or Vaporized Hydrogen Peroxide) so that the packaging and its seals maintain barrier properties and do not produce harmful residues or unacceptable changes in mechanical behavior.

Common packaging materials

Packaging typically combines films, foils, nonwovens, papers, and adhesives. Typical polymers include low‑density and high‑density polyethylene (LDPE/HDPE), polypropylene (PP), polyethylene terephthalate (PET), polyamide (PA, nylon), polyvinyl chloride (PVC), and specialty barrier polymers such as PVDC or EVOH. Nonwoven Tyvek (spunbond HDPE) and medical-grade papers are also widely used. Adhesives include acrylics, hot-melts (EVA), polyurethane and silicone systems. Sealant layers may be coextruded or laminated to balance heat-sealability, stiffness, and barrier requirements.

How sterilization modalities interact with materials

Each sterilization method imposes distinct physical, chemical, and environmental stresses that can alter polymer chemistry, adhesive bonds, mechanical properties, and barrier performance:

• Ethylene Oxide (EO): A low‑temperature, gaseous sterilant that penetrates packaged goods well. EO is chemically reactive and can alkylate functional groups on polymers and adhesives or plasticizers, potentially causing changes in surface chemistry, discoloration, or extraction of additives. Critical considerations are EO residue (ETO) remaining in the system and the need for sufficient aeration to reduce residuals to acceptable regulatory limits. Moisture and temperature in the EO cycle also affect material interactions; hygroscopic polymers (e.g., polyamide) may undergo hydrolysis under warm, humid EO conditions.
• Gamma irradiation: High‑energy photons create ionization and free radicals in polymers. Outcomes include chain scission (leading to reduced molecular weight, loss of tensile strength, embrittlement), crosslinking (which may increase stiffness and raise melting temperatures), oxidation (yellowing, surface changes), and generation of volatile degradation products. Polyolefins (PE, PP) are prone to chain scission and oxidative degradation unless stabilized; PVC can dehydrochlorinate. Dose and dose rate matter—common sterilization doses for disposables are around 25 kGy, but higher doses magnify effects.
• Vaporized Hydrogen Peroxide (VHP): An oxidative, low‑temperature sterilant applied in gaseous or vapor form. VHP can oxidize susceptible polymers and adhesive chemistries, leading to surface etching, embrittlement, discoloration, and compromised adhesive bonds. Because VHP is highly reactive, materials with peroxide‑sensitive additives or dyes may degrade. VHP leaves minimal residue (it decomposes to water and oxygen), but its oxidative impact on materials must be evaluated.

Mechanisms of material degradation

At the engineering level, sterilization causes several primary chemical and physical transformations:

• Chain scission and molecular weight loss — reduces mechanical strength and elongation (common with gamma in polyolefins).
• Crosslinking — increases stiffness, reduces melt flow, and can embrittle or change sealability (seen in some polymers under irradiation).
• Oxidative degradation — surface oxidation, discoloration, and formation of carbonyl groups; often follows radical formation during irradiation or exposure to oxidants like VHP.
• Hydrolysis — cleavage of susceptible bonds (esters, amides) under heat and humidity; relevant for polyesters and polyamides during humid EO cycles.
• Plasticizer loss and additive extraction — volatility or chemical reaction can remove softeners that provide flexibility, producing embrittlement and increased permeability.
• Adhesive cleavage and seal failure — adhesives can lose tack, cohesion, or cure under sterilant exposure, causing reduced seal strength, peel anomalies, or pack failure.

Performance consequences

Degradation can alter permeability (increased water vapor or oxygen transmission), mechanical properties (reduced tensile strength, lower elongation at break), barrier integrity (microcracks, compromised seal), appearance (yellowing, haze), and compatibility with the packaged product (generation of extractables or residues). For sterile packaging, the most critical consequences are loss of sterility assurance due to seal failure or increased permeability and the potential for harmful residues or extractables that could adversely affect the product or patient.

Testing and validation

Material selection and package design must be validated under real process conditions. Common tests include tensile and elongation testing, seal strength and peel testing, burst and leak tests (dye ingress, bubble test), water vapor transmission rate (WVTR), oxygen transmission, differential scanning calorimetry (DSC), gel permeation chromatography (GPC) for molecular weight, Fourier‑transform infrared spectroscopy (FTIR) for chemical changes, colorimetry, and headspace or solvent extraction followed by GC‑MS for residues and volatile degradation products. Real‑time and accelerated aging studies after sterilization verify shelf life and performance.

Design and material selection best practices

For a robust sterile package system:

• Determine the sterilization modality early in product development; packaging must be designed around the sterilization method, not vice versa.
• Use materials and adhesives with known compatibility to the chosen sterilant and dose; request supplier data and material certificates for sterilization exposure.
• Specify stabilizers (antioxidants, UV stabilizers) or barrier layers when appropriate to protect susceptible polymers from oxidative or radiation damage.
• Run representative process validation tests: package the final product, apply the intended sterilization cycle, then perform functional and chemical analyses per regulatory standards (ISO 11607 series for terminally sterilized medical devices, ISO 11135 for EO, ISO 11137 for radiation sterilization).
• Design for seal robustness: choose sealant layer compositions and seal parameters that tolerate the thermal/chemical exposures expected in sterilization and storage.
• Evaluate residues and conduct extractables/leachables studies where patient exposure is possible (e.g., implants, drug containers).

Examples

Tyvek (spunbond HDPE) is widely used because it tolerates EO and gamma well and provides a microbial barrier while allowing sterile transfer; however, gamma can embrittle some nonwovens at high doses. PET films typically show good dimensional stability to gamma but may yellow. Polyolefins are often economical but can suffer chain scission with irradiation unless stabilized. Acrylic adhesives are generally more oxidation‑resistant than natural rubber adhesives, which can degrade in VHP or after irradiation.

Regulatory and operational notes

Standards such as ISO 11607 (packaging for terminally sterilized medical devices), ISO 11135 (EO sterilization), and ISO 11137 (radiation sterilization) define testing, validation, and sterility assurance expectations. Manufacturers must document compatibility testing, sterilization cycle parameters, and residuals/aeration data for EO. Close collaboration with material suppliers, sterilization providers, and design engineers reduces risk and avoids costly rework.

Summary

Sterile packaging is not only a physical barrier but a system that must remain stable under the chosen sterilization environment. Understanding the chemical and thermal stability of polymers, adhesives, and additives, running appropriate validation tests, and selecting materials and designs tailored to the sterilization modality are essential steps to ensure sterility assurance, product safety, and reliable shelf life.